Cargando…
Effect of 2 mg Versus 4 mg of Intravenous Zoledronic Acid on Bone Mineral Density at the Lumbar Spine in Indian Postmenopausal Women with Osteoporosis: A Double-blind Parallel-arm Randomized Controlled Trial
OBJECTIVE: The primary purpose was to compare the effect of 2 mg and 4 mg of intravenous zoledronic acid (ZA) on change in the lumbar spine (LS) bone mineral density (BMD) at the end of 1 year in postmenopausal women with osteoporosis. The secondary objectives were changes in BMD at the total hip an...
Autores principales: | Durgia, Harsh, Kamalanathan, Sadishkumar, Ramkumar, Govindarajalou, Sarkar, Sonali, Reddy, Sagili Vihaya Bhaskar, Sahoo, Jayaprakash, Palui, Rajan, Raj, Henith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420937/ https://www.ncbi.nlm.nih.gov/pubmed/34527611 http://dx.doi.org/10.4103/jrpp.JRPP_20_130 |
Ejemplares similares
-
Role of bisphosphonates in the management of acute Charcot foot
por: Durgia, Harsh, et al.
Publicado: (2018) -
Response to Zoledronic Acid in Patients with Active Paget's Disease of Bone: A Retrospective Study
por: Durgia, Harsh, et al.
Publicado: (2019) -
Timing of osteoporosis therapies following fracture: the current
status
por: Palui, Rajan, et al.
Publicado: (2022) -
SGLT-2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A systematic review
por: Raj, Henith, et al.
Publicado: (2019) -
Abstract 41: Effect of zoledronic acid on bone mineral density in Indian postmenopausal osteoporotic women with and without diabetes – A prospective cohort study
por: Merugu, Chandhana, et al.
Publicado: (2022)